Smith & Nephew Continues to Struggle Since the Pandemic -- Market Talk

Dow Jones10-31

1138 GMT - Smith & Nephew has walked a rocky path since the pandemic led to elective surgeries being cancelled, AJ Bell Investment Director Russ Mould writes in a note. "Many planned hip and knee replacements were pushed back, reducing demand for Smith & Nephew's orthopedic products, while its supply chain was also disrupted," Mould says. The U.K. medical-technology company's rough post-pandemic comeback has attracted activist investor Cevian Capital, which was in search of an opportunity. While there is a lot of work needed to fix the company, the latest performance is likely to be disappointing for Cevian, Mould says. Shares are down 13.5% at 950.20 pence. (najat.kantouar@wsj.com)

(END) Dow Jones Newswires

October 31, 2024 07:38 ET (11:38 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2479326700?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 19:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479326700","market":"sg","top_or_hot":-1,"title":"Smith & Nephew Continues to Struggle Since the Pandemic -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1138 GMT - Smith &amp; Nephew has walked a rocky path since the pandemic led to elective surgeries being cancelled, AJ Bell Investment Director Russ Mould writes in a note. \"Many planned hip and knee replacements were pushed back, reducing demand for Smith &amp; Nephew's orthopedic products, while its supply chain was also disrupted,\" Mould says. The U.K. medical-technology company's rough post-pandemic comeback has attracted activist investor Cevian Capital, which was in search of an opportunity. While there is a lot of work needed to fix the company, the latest performance is likely to be disappointing for Cevian, Mould says. Shares are down 13.5% at 950.20 pence. (najat.kantouar@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 31, 2024 07:38 ET (11:38 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Smith & Nephew Continues to Struggle Since the Pandemic -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSmith & Nephew Continues to Struggle Since the Pandemic -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-31 19:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1138 GMT - Smith & Nephew has walked a rocky path since the pandemic led to elective surgeries being cancelled, AJ Bell Investment Director Russ Mould writes in a note. \"Many planned hip and knee ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNN","symbol_name":"Smith & Nephew PLC ADS","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2479326700","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479326700","pubTimestamp":1730374680,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1138 GMT - Smith & Nephew has walked a rocky path since the pandemic led to elective surgeries being cancelled, AJ Bell Investment Director Russ Mould writes in a note. \"Many planned hip and knee replacements were pushed back, reducing demand for Smith & Nephew's orthopedic products, while its supply chain was also disrupted,\" Mould says. The U.K. medical-technology company's rough post-pandemic comeback has attracted activist investor Cevian Capital, which was in search of an opportunity. While there is a lot of work needed to fix the company, the latest performance is likely to be disappointing for Cevian, Mould says. Shares are down 13.5% at 950.20 pence. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNN":"Smith & Nephew PLC ADS","BK4082":"医疗保健设备"},"translate_title":"自大流行以来，施乐辉(Smith&Nephew)继续陷入困境——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNN":0.9},"content_text":"1138 GMT - Smith & Nephew has walked a rocky path since the pandemic led to elective surgeries being cancelled, AJ Bell Investment Director Russ Mould writes in a note. \"Many planned hip and knee replacements were pushed back, reducing demand for Smith & Nephew's orthopedic products, while its supply chain was also disrupted,\" Mould says. The U.K. medical-technology company's rough post-pandemic comeback has attracted activist investor Cevian Capital, which was in search of an opportunity. While there is a lot of work needed to fix the company, the latest performance is likely to be disappointing for Cevian, Mould says. Shares are down 13.5% at 950.20 pence. (najat.kantouar@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 31, 2024 07:38 ET (11:38 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479326700"}